Systematic Investigation of Berberine for Treating Hepatocellular Carcinoma Based on Network Pharmacology

Systematic Investigation of Berberine for Treating Hepatocellular Carcinoma Based on Network Pharmacology

Objective: Liver cancer is the 4th leading cause of cancer death worldwide,and hepatocellular carcinoma (HCC) accounts for the largest proportion of these deaths. Berberine is a quaternary amine compound extracted from plants such as Coptidis Rhizoma (Huang Lian, 黄连) and Phellodendri Chinensis Corte...

Full description

Bibliographic Details
Main Authors:	Mu Jie, Liu Hai-Xia, Tang Fei-Fei, Liu Shu-Ling, Feng Tian-Yi, Wang Xue-Qian, Wang Qing-Guo, Cheng Fa-Feng
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2019-09-01
Series:	Digital Chinese Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589377719301077

Similar Items

Research progress on pharmacological action and effective drug carrier of berberine
by: Yue Liu, et al.
Published: (2020-09-01)

Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
by: Yunfeng Han, et al.
Published: (2021-01-01)

Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth—A Small Molecule Inhibitor, Berberine
by: Wei Guo, et al.
Published: (2020-07-01)

The status of and trends in the pharmacology of berberine: a bibliometric review [1985–2018]
by: Yu Gao, et al.
Published: (2020-01-01)

Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
by: Nan Jiang, et al.
Published: (2021-03-01)

Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
by: Xuejiao Xie, et al.
Published: (2020-01-01)

Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines
by: Tung-Yueh Chuang, et al.
Published: (2017-05-01)

Study progress of berberine for treating cardiovascular disease
by: Le-Min Xia, et al.
Published: (2015-12-01)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency
by: Yan M, et al.
Published: (2015-10-01)

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
by: Jihan Huang, et al.
Published: (2020-04-01)

Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology
by: Benjiao Gong, et al.
Published: (2018-01-01)

Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine
by: Xuanbin Wang, et al.
Published: (2016-04-01)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency [Corrigendum]
by: Yan M, et al.
Published: (2016-11-01)

Application of Berberine on Treating Type 2 Diabetes Mellitus
by: Bing Pang, et al.
Published: (2015-01-01)

Network Pharmacology-Based Study on the Mechanism of Scutellariae Radix for Hepatocellular Carcinoma Treatment
by: Qian Wang, et al.
Published: (2020-01-01)

Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis
by: Fengna Yan, et al.
Published: (2020-11-01)

Mechanism of Aidi injection on hepatocellular carcinoma based on network pharmacology
by: Yuan-Yuan Ding, et al.
Published: (2020-04-01)

Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma
by: Chongyang Ma, et al.
Published: (2019-01-01)

Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
by: Chaohe Zhang, et al.
Published: (2020-01-01)

Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
by: Wei Guo, et al.
Published: (2019-10-01)

Pharmacological Mechanisms Underlying the Hepatoprotective Effects of Ecliptae herba on Hepatocellular Carcinoma
by: Botao Pan, et al.
Published: (2021-01-01)

The preventive and curative potential of berberine and coptis on humanhepatocellular carcinoma
by: Wang, Ning, Michael., et al.
Published: (2013)

and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01)

Hydrochloric acid-enhanced radiofrequency ablation for treating a large hepatocellular carcinoma with spontaneous rapture: a case report
by: Jin-Hua Huang, et al.
Published: (2017-01-01)

Pharmacological evaluation and mechanistic study of compound Xishu Granule in hepatocellular carcinoma
by: Pin Li, et al.
Published: (2020-09-01)

Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats
by: Yan Che, et al.
Published: (2019-10-01)

Ablation therapy for large hepatocellular carcinoma
by: CAO Fei
Published: (2021-03-01)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
by: Qian‐Wen Rao, et al.
Published: (2020-11-01)

Survival analysis of patients with medium and advanced hepatocellular carcinoma treated by TACE combined with Endostar
by: Xiu-Heng Qi, et al.
Published: (2020-10-01)

Size measurements of hepatocellular carcinoma: comparisons between contrast and two-dimensional ultrasound
by: Fei Chen, et al.
Published: (2020-11-01)

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology
by: Pengfei Guo, et al.
Published: (2019-08-01)

Berberine-Coated Biomimetic Composite Microspheres for Simultaneously Hemostatic and Antibacterial Performance
by: Xiaojian Zhang, et al.
Published: (2021-01-01)

Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology
by: Yan Jiang, et al.
Published: (2021-01-01)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
by: Ester Gonzalez-Sanchez, et al.
Published: (2021-06-01)

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
by: Xinchi Feng, et al.
Published: (2021-01-01)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021-07-01)

Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
by: Xinmei Xu, et al.
Published: (2021-01-01)

Expression of transcription factor Sp1 in hepatocellular carcinoma
by: FENG Jie
Published: (2013-01-01)

Patterns of Comorbidity in Hepatocellular Carcinoma: A Network Perspective
by: Xiao-Min Mu, et al.
Published: (2020-04-01)

The Hepatoprotective Effect of Curcumin and Berberine
by: Hsi-Mu Chen, et al.
Published: (101)